144 related articles for article (PubMed ID: 17893902)
21. PseG of pseudaminic acid biosynthesis: a UDP-sugar hydrolase as a masked glycosyltransferase.
Liu F; Tanner ME
J Biol Chem; 2006 Jul; 281(30):20902-20909. PubMed ID: 16728396
[TBL] [Abstract][Full Text] [Related]
22. Searching for potent and specific antibiotics against pathogenic Helicobacter and Campylobacter strains.
Ogasawara Y; Dairi T
J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):409-414. PubMed ID: 30460507
[TBL] [Abstract][Full Text] [Related]
23. 2-substituted-3-dehydroquinic acids as potent competitive inhibitors of type II dehydroquinase.
Prazeres VF; Castedo L; Lamb H; Hawkins AR; González-Bello C
ChemMedChem; 2009 Dec; 4(12):1980-4. PubMed ID: 19856378
[No Abstract] [Full Text] [Related]
24. Pseudaminic acid, the major modification on Campylobacter flagellin, is synthesized via the Cj1293 gene.
Goon S; Kelly JF; Logan SM; Ewing CP; Guerry P
Mol Microbiol; 2003 Oct; 50(2):659-71. PubMed ID: 14617187
[TBL] [Abstract][Full Text] [Related]
25. Flagellin glycosylation with pseudaminic acid in Campylobacter and Helicobacter: prospects for development of novel therapeutics.
Salah Ud-Din AIM; Roujeinikova A
Cell Mol Life Sci; 2018 Apr; 75(7):1163-1178. PubMed ID: 29080090
[TBL] [Abstract][Full Text] [Related]
26. Large molecules as anti-adhesive compounds against pathogens.
Wittschier N; Lengsfeld C; Vorthems S; Stratmann U; Ernst JF; Verspohl EJ; Hensel A
J Pharm Pharmacol; 2007 Jun; 59(6):777-86. PubMed ID: 17637170
[TBL] [Abstract][Full Text] [Related]
27. Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease.
Xiao ZP; Shi DH; Li HQ; Zhang LN; Xu C; Zhu HL
Bioorg Med Chem; 2007 Jun; 15(11):3703-10. PubMed ID: 17400458
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Helicobacter pylori aminoacyl-tRNA amidotransferase by chloramphenicol analogs.
Balg C; De Mieri M; Huot JL; Blais SP; Lapointe J; Chênevert R
Bioorg Med Chem; 2010 Nov; 18(22):7868-72. PubMed ID: 20943400
[TBL] [Abstract][Full Text] [Related]
29. A picomolar transition state analogue inhibitor of MTAN as a specific antibiotic for Helicobacter pylori.
Wang S; Haapalainen AM; Yan F; Du Q; Tyler PC; Evans GB; Rinaldo-Matthis A; Brown RL; Norris GE; Almo SC; Schramm VL
Biochemistry; 2012 Sep; 51(35):6892-4. PubMed ID: 22891633
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Antimicrobial Evaluation of Amixicile-Based Inhibitors of the Pyruvate-Ferredoxin Oxidoreductases of Anaerobic Bacteria and Epsilonproteobacteria.
Kennedy AJ; Bruce AM; Gineste C; Ballard TE; Olekhnovich IN; Macdonald TL; Hoffman PS
Antimicrob Agents Chemother; 2016 Jul; 60(7):3980-7. PubMed ID: 27090174
[TBL] [Abstract][Full Text] [Related]
31. NMR spectroscopic characterization of the sialyltransferase CstII from Campylobacter jejuni: histidine 188 is the general base.
Chan PH; Lairson LL; Lee HJ; Wakarchuk WW; Strynadka NC; Withers SG; McIntosh LP
Biochemistry; 2009 Dec; 48(47):11220-30. PubMed ID: 19824695
[TBL] [Abstract][Full Text] [Related]
32. Why is CMP-ketodeoxyoctonate highly unstable?
Lin CH; Murray BW; Ollmann IR; Wong CH
Biochemistry; 1997 Jan; 36(4):780-5. PubMed ID: 9020775
[TBL] [Abstract][Full Text] [Related]
33. Sensitivity of different Campylobacter jejuni and Escherichia coli O157:H7 strains to mild bactericidal treatments.
Smigic N; Rajkovic A; Devlieghere F
Commun Agric Appl Biol Sci; 2008; 73(1):209-12. PubMed ID: 18831276
[No Abstract] [Full Text] [Related]
34. Exiguaquinol: a novel pentacyclic hydroquinone from Neopetrosia exigua that inhibits Helicobacter pylori MurI.
de Almeida Leone P; Carroll AR; Towerzey L; King G; McArdle BM; Kern G; Fisher S; Hooper JN; Quinn RJ
Org Lett; 2008 Jun; 10(12):2585-8. PubMed ID: 18489104
[TBL] [Abstract][Full Text] [Related]
35. In vitro inhibition of Helicobacter pylori urease with non and semi fermented Camellia sinensis.
Hassani AR; Ordouzadeh N; Ghaemi A; Amirmozafari N; Hamdi K; Nazari R
Indian J Med Microbiol; 2009; 27(1):30-4. PubMed ID: 19172056
[TBL] [Abstract][Full Text] [Related]
36. [Increased risk of stomach disease with proton pump inhibitors].
Sandqvist A; Dahlqvist R
Lakartidningen; 2008 Apr 23-May 6; 105(17-18):1300-1. PubMed ID: 18561533
[No Abstract] [Full Text] [Related]
37. Prevalence of Campylobacter jejuni and its resistance to antibiotics in poultry in the Czech Republic.
Bardon J; Kolar M; Cekanova L; Hejnar P; Koukalova D
Zoonoses Public Health; 2009 Apr; 56(3):111-6. PubMed ID: 18771516
[TBL] [Abstract][Full Text] [Related]
38. Structural studies on the Pseudomonas aeruginosa sialidase-like enzyme PA2794 suggest substrate and mechanistic variations.
Xu G; Ryan C; Kiefel MJ; Wilson JC; Taylor GL
J Mol Biol; 2009 Feb; 386(3):828-40. PubMed ID: 19166860
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel scaffolds for potential anti-Helicobacter pylori agents based on the crystal structure of H. pylori 3-deoxy-d-manno-octulosonate 8-phosphate synthase (HpKDO8PS).
Cho S; Im H; Lee KY; Chen J; Kang HJ; Yoon HJ; Min KH; Lee KR; Park HJ; Lee BJ
Eur J Med Chem; 2016 Jan; 108():188-202. PubMed ID: 26649906
[TBL] [Abstract][Full Text] [Related]
40. Structural and kinetic analysis of substrate binding to the sialyltransferase Cst-II from Campylobacter jejuni.
Lee HJ; Lairson LL; Rich JR; Lameignere E; Wakarchuk WW; Withers SG; Strynadka NCJ
J Biol Chem; 2011 Oct; 286(41):35922-35932. PubMed ID: 21832050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
